Kawasaki, Japan

Tomohiro Emi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sb-Kawasumi Laboratories, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiro Emi. Retrieved from https://idiyas.com/inventor/tomohiro-emi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomohiro Emi: Inventor of an Indwelling Device

Introduction

Tomohiro Emi is an inventor associated with Kawasaki, Japan, and Sb-Kawasumi Laboratories, Inc. His patent work concerns an indwelling device designed to interact with a tubular treatment device.

Latest Patents

Emi is credited with 1 patent, titled “Indwelling Device.” The invention describes a shaft-shaped member with an engaged portion that connects with an engaging portion of a tubular treatment device. A linear member works with a restriction portion to limit the engaging portion’s radial expansion. Releasing the linear member’s winding removes that restriction and allows the engaging portion to expand.

Career Highlights

The available information identifies Emi’s work at Sb-Kawasumi Laboratories, Inc., and highlights his contribution to the patented indwelling-device design.

Collaborations

Emi’s listed coworkers include Naoaki Yamamoto and Takashi Yoshimori.

Conclusion

Tomohiro Emi’s patent reflects a focused contribution to medical-device technology, using a controllable restriction mechanism to support engagement between an indwelling device and a tubular treatment device.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…